Scott Grossman

2.4k total citations
58 papers, 1.8k citations indexed

About

Scott Grossman is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Scott Grossman has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 13 papers in Pharmacology. Recurrent topics in Scott Grossman's work include Pharmacogenetics and Drug Metabolism (12 papers), Neuroscience and Neuropharmacology Research (9 papers) and Metal complexes synthesis and properties (9 papers). Scott Grossman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Neuroscience and Neuropharmacology Research (9 papers) and Metal complexes synthesis and properties (9 papers). Scott Grossman collaborates with scholars based in United States, Germany and United Kingdom. Scott Grossman's co-authors include David J. Jollow, Donglu Zhang, J. S. Macdonald, Brad D. Maxwell, Nirmala Raghavan, Lifei Wang, Peter F. Smith, Kan He, R. S. Eydelloth and John I. Germershausen and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Scott Grossman

58 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Grossman United States 25 442 372 272 212 190 58 1.8k
Sven Björkman Sweden 40 691 1.6× 150 0.4× 377 1.4× 66 0.3× 412 2.2× 127 4.5k
Harvey M. Solomon United States 24 513 1.2× 158 0.4× 264 1.0× 38 0.2× 234 1.2× 76 1.7k
Bing Zhu United States 24 440 1.0× 104 0.3× 412 1.5× 35 0.2× 421 2.2× 100 1.9k
Frank F. Sun United States 28 700 1.6× 214 0.6× 215 0.8× 31 0.1× 230 1.2× 52 2.5k
Karl Oettl Austria 25 786 1.8× 151 0.4× 96 0.4× 24 0.1× 162 0.9× 66 2.3k
Shigeo Baba Japan 16 333 0.8× 335 0.9× 117 0.4× 51 0.2× 43 0.2× 127 1.2k
Horst Schweer Germany 28 727 1.6× 198 0.5× 105 0.4× 22 0.1× 53 0.3× 113 2.4k
Jinping Gan United States 22 569 1.3× 93 0.3× 436 1.6× 29 0.1× 466 2.5× 61 1.7k
Nigel S. Cook Switzerland 24 1.4k 3.1× 732 2.0× 64 0.2× 41 0.2× 51 0.3× 63 2.6k
Mark J. Rose United States 23 794 1.8× 62 0.2× 239 0.9× 26 0.1× 334 1.8× 49 2.7k

Countries citing papers authored by Scott Grossman

Since Specialization
Citations

This map shows the geographic impact of Scott Grossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Grossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Grossman more than expected).

Fields of papers citing papers by Scott Grossman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Grossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Grossman. The network helps show where Scott Grossman may publish in the future.

Co-authorship network of co-authors of Scott Grossman

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Grossman. A scholar is included among the top collaborators of Scott Grossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Grossman. Scott Grossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grossman, Scott, Colin W. G. Fishwick, & Martin J. McPhillie. (2023). Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV. Pharmaceuticals. 16(2). 261–261. 9 indexed citations
2.
Grossman, Scott, Thomas Germe, Lauren R. Abbott, et al.. (2022). De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region. RSC Medicinal Chemistry. 13(7). 831–839. 5 indexed citations
3.
Soukarieh, Fadi, William Richardson, Manuel Romero, et al.. (2021). Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa. ACS Infectious Diseases. 7(9). 2666–2685. 28 indexed citations
4.
Grossman, Scott, Fadi Soukarieh, William Richardson, et al.. (2020). Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR. European Journal of Medicinal Chemistry. 208. 112778–112778. 40 indexed citations
5.
He, Kan, Joseph M. Luettgen, Donglu Zhang, et al.. (2011). Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor. European Journal of Drug Metabolism and Pharmacokinetics. 36(3). 129–139. 71 indexed citations
6.
Wang, Lifei, Kan He, Brad D. Maxwell, et al.. (2010). Tissue Distribution and Elimination of [14C]Apixaban in Rats. Drug Metabolism and Disposition. 39(2). 256–264. 48 indexed citations
7.
Wang, Lifei, Donglu Zhang, Nirmala Raghavan, et al.. (2009). In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies. Drug Metabolism and Disposition. 38(3). 448–458. 212 indexed citations
8.
Zhang, Donglu, Kan He, Nirmala Raghavan, et al.. (2009). Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans. Drug Metabolism and Disposition. 37(8). 1738–1748. 89 indexed citations
9.
Wong, Harvey, James E. Grace, Matthew Wright, et al.. (2006). Glucuronidation in the chimpanzee (Pan troglodytes): Studies with acetaminophen, oestradiol and morphine. Xenobiotica. 36(12). 1178–1190. 5 indexed citations
10.
Wong, Harvey, Scott Grossman, Stephen A. Bai, et al.. (2004). THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION. Drug Metabolism and Disposition. 32(12). 1359–1369. 21 indexed citations
11.
12.
Arvanitis, Argyrios G., Richard G. Wilde, Lawrence W. Fitzgerald, et al.. (2003). Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligands. Bioorganic & Medicinal Chemistry Letters. 13(1). 129–131. 7 indexed citations
13.
Arvanitis, Argyrios G., Richard G. Wilde, Gary A. Cain, et al.. (2003). Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands. Bioorganic & Medicinal Chemistry Letters. 13(1). 125–128. 11 indexed citations
14.
Prahalada, S., Linda Rhodes, Scott Grossman, et al.. (1998). Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-Alpha reductase Inhibitor. The Prostate. 35(3). 157–164. 33 indexed citations
15.
Grossman, Scott, et al.. (1997). Hepatotoxicity of an HIV Protease Inhibitor in Dogs and Rats. Toxicology and Applied Pharmacology. 146(1). 40–52. 5 indexed citations
16.
Grossman, Scott, Diane R. Umbenhauer, D Patrick, et al.. (1993). CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.. Drug Metabolism and Disposition. 21(6). 1029–1036. 16 indexed citations
17.
Smith, Peter F., Paul C. Stromberg, R. S. Eydelloth, et al.. (1992). Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicology and Applied Pharmacology. 116(1). 71–77. 58 indexed citations
18.
Grossman, Scott, et al.. (1992). Dapsone-induced hemolytic anemia: Effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes. Toxicology and Applied Pharmacology. 117(2). 208–217. 42 indexed citations
19.
Smith, Philip, R. S. Eydelloth, Scott Grossman, et al.. (1992). Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cydosposin A: evaluation in a rat model. European Heart Journal. 13(suppl B). 2–6. 18 indexed citations
20.
Grossman, Scott & David J. Jollow. (1988). Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.. Journal of Pharmacology and Experimental Therapeutics. 244(1). 118–125. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Björkman Breakdown of academic impact, for papers by Harvey M. Solomon Breakdown of academic impact, for papers by Bing Zhu Breakdown of academic impact, for papers by Frank F. Sun Breakdown of academic impact, for papers by Karl Oettl Breakdown of academic impact, for papers by Shigeo Baba Breakdown of academic impact, for papers by Horst Schweer Breakdown of academic impact, for papers by Jinping Gan Breakdown of academic impact, for papers by Nigel S. Cook Breakdown of academic impact, for papers by Mark J. Rose
Rankless by CCL
2026